Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 20, 2016 (10 years ago)

Placebo for Prednisolone Acetate 1%

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Placebo for Prednisolone Acetate 1%, Oph Suspension, 10 mL Dropper Bottle, Compounded by Leiter's Compounding, San Jose, CA

Drug: Prednisolone

Recalling firm
Leiter's Compounding
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0017-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Prednisolone recalls

See all

Other recalls by Leiter's Compounding

All 2016 recalls
Class II · Moderate risk

Mitomycin 0.02%

Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Terminated Sterility / contamination Leiter's Compounding NDC 70360-005-35 D-0015-2017